30
nanotimes
Companies Facts
Infineon’s revenues in the first quarter of the 2011 fiscal year were Euro922 million, down two percent compared to the fourth quarter of the 2010 fiscal year.
http://www.infineon.com/USB3.0protection http://www.infineon.com/sensors
I
tN Nanovation AG (ISIN: DE000A0JL461), Germany has announced the signing of a conditional equity
investment agreement of up to EUR15 million with YA Global Master SPV Ltd., which is managed by Yorkville Advisors, LLC, a large U.S.-based invest- ment group.
Under the agreement, ItN Nanovation has the right to issue new shares to YA Global in one or more tranches over the next three years for a total amount of up to EUR15 million, thereby ensuring that it has a strong equity capital base to support its ongoing growth.
ItN Nanovation retains full discretion as to whether, and to what extent, it exercises these rights. The agreement thus provides the company with a high degree of flexibility in its financial planning, enabling it to capitalize on growth opportunities as they arise.
http://www.itn-nanovation.de
manufacturer with low-cost operations based in Chi- na, has entered into a commercial agreement with Innovalight, Inc., a privately-held company based in Sunnyvale, California, that manufactures proprietary silicon ink and licenses proprietary processing tech-
J
inkoSolar Holding Co., Ltd. (NYSE: JKS), a fast-growing vertically integrated solar product
nology to solar cell manufacturing companies. Under the terms of the agreement, JinkoSolar will purchase silicon ink from Innovalight and license Innovalight‘s processing technology to produce solar cells with higher conversion efficiencies.
“JinkoSolar‘s strong brand presence across a broad geographic network makes the company an impor- tant customer for us,” added Conrad Burke, Chief Executive Officer at Innovalight. “Our silicon ink technology, in combination with JinkoSolar‘s leading vertically integrated manufacturing platform, will offer an attractive and highly powerful solar product. We look forward to working with JinkoSolar as we partner to bring a progressive technology and impro- ved solar product to the market.”
Innovalight‘s proprietary nanotechnology-based silicon ink and processing platform provide a simple upgrade to solar cell manufacturing production lines that boosts the performance of solar cells and lo- wers production costs. With Innovalight technology, JinkoSolar expects to produce monocrystalline solar cells with conversion efficiencies greater than 18.6% in the first half of 2011.
http://www.innovalight.com http://www.jinkosolar.com
K
INAXO Biotechnologies GmbH has entered into a collaboration with AstraZeneca. Under the terms
of the agreement, KINAXO will apply its technology platform to support one of AstraZeneca’s oncolo- gy programs. KINAXO will employ high-end mass spectrometry-based technologies to quantitatively analyze posttranslational protein modifications on a proteome-wide scale. Since protein modifications play pivotal roles in many cellular processes (e.g. cell
11-01 :: December 2010 / January 2011
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95